Cardiac necrosis markers associated with low nitric oxide levels in the plasma of rabbits after treatment with vasopressin: Protective effects of nitroglycerin administration

Pharmacological Research

Volumn 45, Issue 6, 2002, Pages 427-434

  Pinelli, Arnaldo ^a   Trivulzio, Silvio ^a   Tomasoni, Livio ^a   Bertolini, Boris ^a   Brenna, Sergio ^b   Bonacina, Edgardo ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b Laboratory of Clinical Chemistry

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Arginine vasopressin; Blood pressure; Cardiac necrosis markers; Coagulation parameters; Electrocardiogram; Heart rate; Nitric oxide; Nitrite; Nitroglycerin; Plasma; Rabbits

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; GLYCERYL TRINITRATE; MYOGLOBIN; NITRIC OXIDE; TROPONIN I; VASOPRESSIN;

ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRUG EFFECT; ELECTROCARDIOGRAM; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; NONHUMAN; PLASMA; PRIORITY JOURNAL; RABBIT; SCREENING; ST SEGMENT; THROMBOSIS; VASOCONSTRICTION;

EID: 0036428015     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2002.0967     Document Type: Article

References (65)

1. Nakano J. Studies on the cardiovascular effects of synthetic vaso-pressin. J Pharmacol Exp Ther 1967; 157: 19-31.
2. Corliss RJ, McKenna DH, Sialer S, O'Brien GS, Rowe GC. Systemic and coronary hemodynamic effects of vasopressin. Am J Med Sci 1968; 256: 293-9.
3. Heyndrickx GR, Boettcher DH, Vatner V. Effects of angiotensin, vasopressin and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am J Physiol 1976; 231: 1579-89.
4. Khayyal MA, Eng C, Franzen D, Breall JA, Kirk ES. Effects of vasopressin on the coronary circulation: Reserve and regulation during ischemia. Am J Physiol 1985; 248: H516-22.
5. Myers PR, Banitt PF, Guerra R Jr, Harrison DG. Characteristics of canine coronary resistance arteries: Importance of endothelium. Am J Physiol 1989; 257: H603-10.
6. Maturi MF et al. Coronary vasoconstriction induced by vaso-pressin. Production of myocardial ischemia in dogs by constriction of nondiseased small vessels. Circulation 1991; 83: 2111-21.
7. Garcia-Villalon AL, Garcia JL, Fernandez N, Monge L, Gomez B, Dieguez G. Regional differences in the arterial response to vasopressin: Role of endothelial nitric oxide. Br J Pharmacol 1996; 118: 1848-54.
8. 2 receptors and nitric oxide. Eur J Pharmacol 1998; 342: 225-33.
9. Hiramatsu Y, Izumi A, Tezuka T, Kurosawa Y. Antagonizing substances obtained from whale heart extract to vasopressin induced myocardial hypoxia. Jpn J Pharmacol 1970; 20: 313-24.
10. Uchida W, Shibasaki K, Asano M, Takenaka T. Antianginal effect of YM-16151-4 in various experimental anginal models. J Cardiovas Pharmacol 1993; 21: 701-8.
11. Mori T, Ishigai Y, Fukuzawa A, Chiba K, Shibano T. Pharmacological profile of semotiadil fumarate, a novel calcium antagonist, in rat experimental angina model. Br J Pharmacol 1995; 116: 1668-72.
12. Shibasaki K, Arai Y, Uchida W, Okazaki T, Asano M, Takenaka T. Antianginal effect of YM430, a novel calcium entry-blocking and beta-adrenoceptor-blocking agent in several experimental angina models. General Pharmacol 1997; 29: 545-50.
13. Caprino L, Borrelli F, Falchetti R. Effect of phosvitin on electrocardiographic changes produced by vasopressin in rats. Experientia 1973; 29: 679-80.
14. Wang JX, Maruyama K, Murakami M, Endo T, Komatsu H, Akahane M. Antianginal effects of ranolazine in various experimental models of angina. Arzneimittelforschung 1999; 49: 193-9.
15. Yamamoto S, Matsui K, Sasabe M, Kitano M, Ohashi N. Effect of SMP-300, a new Na+/H+ exchange inhibitor, on myocardial ischemia and experimental angina models in rats. Jpn J Pharmacol 2000; 84: 196-205.
16. Sambhi MP, White FN. The electrocardiogram of the normal and hypertensive rat. Circ Res 1960; 8: 129-34.
17. Norman SJ, Priest RE, Benditt EP. Electrocardiogram in the normal rat and its alteration with experimental coronary occlusion. Circ Res 1961; 19: 282-7.
18. Valora A, Fidanza A. L'elettrocardiogramma del ratto. Casa editrice idelson. Napoli 1963.
19. Bertsch T, Bleuel H, Aufenanger J, Rebel W. Comparison of cardiac Troponin T and cardiac Troponin I concentrations in peripheral blood during orciprenaline induced tachycardia in rats. Exp Toxicol Pathol 1997; 49: 467-8.
20. Bertsch T, Bleuel H, Deschl U, Rebel W. A new sensitive cardiac Troponin T rapid test (TROPT) for the detection of experimental acute myocardial damage in rats. Exp Toxicol Path 1999; 51: 565-9.
21. Kawakami T, Lowbeer C, Valen G, Vaage J. Post-ischemic dysfunction does not correlate with release of cardiac troponin T in isolated rat hearts. Acta Physiol Scand 1999; 167: 23-7.
22. Bertinchant JP et al. Comparison of the diagnostic value of cardiac troponin I and T determination for detecting early myocardial damage and the relationship with histological findings after isoprenaline-induced cardiac injury in rats. Clin Chim Acta 2000; 298: 13-28.
23. O'Brien PJ, Lant Y, Ladenson JH. Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay. Clin Chem 1997; 43: 2333-8.
24. Schror K, Zimmermann KC, Tannhauser R. Augmented myocardial ischemia by nicotine mechanism and their possible significance. Br J Pharmacol 1998; 125: 79-86.
25. Adamcova M, Gersl V, Hrdina R, Melka M, Mazurova Y, Vavrova J, Palicka V, Kokstein Z. Cardiac troponin T as a marker of myocardial damage caused by antineoplastic drugs in rabbits. J Cancer Res Clin Oncol 1999; 125: 268-74.
26. O'Brien PJ, Dameron GW, Beck ML, Kang YJ, Erickson BK, Di Battista TH, Miller KE, Jackson KN, Mittelstadt S.. Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Animal Sci 1997; 47: 486-95.
27. Nilsson IM, Mikaelsson M, Vilhardt H. The effect of intranasal DDAVP on coagulation and fibrinolytic activity in normal persons. Scan J Haematol 1982; 29: 70-4.
28. Grant PJ, Tate GM, Davies JA, Williams NS, Prentice CR. Intra-operative activation of coagulation-A stimulus to thrombosis mediated by vasopressin? Thromb Haemost 1986; 55: 104-7.
29. Kelm M, Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res 1990; 66: 1561-75.
30. Moncada S, Higgs A. The L-arginine nitric oxide pathway. New Engl J Med 1993; 329: 2002-12.
31. Rang HP, Dale MM, Ritter JM. Pharmacology. 4th Edn. Churchill Livingston, 1999: 188-97.
32. Zaman Z, De Spiegeleer S, Gerits M, Blanckaert N. Analytical and clinical performance of two cardiac troponin I immunoassays. Clin Chem Lab Med 1999; 37: 889-97.
33. May JM, Qu ZC, Xia L, Cobb CE. Nitrite uptake and metabolism and oxidant stress in human erythrocytes. Am J Physiol-Cell Physiol 2000; 279: C1946-54.
34. Lauer T, Preik M, Rassaf T, Strauer BE, Deussen A, Feelisch M, Kelm M. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci USA 2001; 98: 12814-9.
35. Marzinzig M, Nussler AK, Stadler J, Marzinzig E, Barthlen W, Nussler NC, Beger HG, Morris SM, Bruckner UB. Improved methods to measure end products of nitric oxide in biological fluids: Nitrite, nitrate and S-nitrosothiols. Nitric Oxide 1997; 1: 177-89.
36. Zaninotto M, Altinier S, Lachin M, Carraro P, Plebani M. Fluoroenzymometric method to measure cardiac troponin I in sera of patients with myocardial infarction. Clin Chem 1996; 42: 1460-6.
37. Plebani M, Zaninotto M. Diagnostic strategies using myoglobin measurement in myocardial infarction. Clin Chem Acta 1998; 272: 69-77.
38. Putney S et al. Rabbit muscle creatine phosphokinase. CDNA cloning, primary structure and detection of human homologues. J Biol Chem 1984; 259: 14317-20.
39. Pickering L, Pang H, Biemann K, Munro H, Schimmel P. Two tissue-specific isozymes of creatine kinase have closely matched amino acid sequences. Proc Natl Acad Sci USA 1985; 82: 2310-4.
40. Perryman MB, Kerner SA, Bohlmeyer TJ, Roberts R. Isolation and sequence analysis of a full-length cDNA for human M creatine kinase. Biochem Biophys Res Comm 1986; 140: 981-9.
41. Villarreal-Levy G, Ma TS, Kerner SA, Roberts R, Perryman MB. Human creatine kinase: Isolation and sequence analysis of cDNA clone for the B subunit, development of subunit specific probes and determination of gene copy number. Biochem Biophys Res Comm 1987; 144: 1116-27.
42. Rao JK, Bujacz G, Wlodawer A. Crystal structure of rabbit muscle creatine kinase. FEBS Lett 1998; 439: 133-7.
43. Wexler BC, Mc Murtry JP. Allopurinol amelioration of the patho-physiology of acute myocardial infarction in rats. Atherosclerosis 1981; 39: 71-87.
44. Pasquinelli F. Diagnostica e Tecniche di Laboratorio. Firenze: Rosini Editrice, 1997.
45. AFIP. Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology. 3rd Edn New York: McGraw-Hill Book Company, 1968.
46. Armitage P. Statistica medica, 10th edn. Milano: Feltrinelli, 1991.
47. Grand RJ, Wilkinson JM. The aminoacid sequence of rabbit cardiac troponin I. Biochem J 1976; 159: 633-41.
48. Malouf NN, McMahon D, Oakeley AE, Anderson PA. A cardiac Troponin T epitope conserved across phyla. J Biol Chem 1992; 267: 9269-74.
49. Ferrieres G, Calzolari C, Mani JC, Laune D, Trinquier S, Laprade M, Larue C, Pau B, Granier C. Human cardiac troponin I: Precise identification of antigenic epitopes and prediction of secondary structure. Clin Chem 1998; 44: 487-93.
50. Lindahl B, Andren B, Ohlsson J, Venge P, Wallentin L. Non-invasive risk stratification in unstable coronary artery disease: Exercise test and biochemical markers. FRISC Study Group. Am J Cardiol 1997; 80: 40E-44E.
51. Giannittsis E, Katus HA. Strategies for clinical assessment of patients with suspected acute coronary syndromes. Scan J Clin Lab Invest 1999; 230(Suppl.): 36-42.
52. Storrow AB, Gibbler WB. The role of cardiac markers in emergency department. Clin Chim Acta 1999; 284: 187-96.
53. White HD. Optimal treatment of patient with acute coronary syndromes and non-ST elevation myocardial infarction. Am Heart J 1999; 138: 105-14.
54. Remppis A, Ehlermann P, Giannitsis E, Greten T, Most P, Muller-Bardorff M, Katus HA. Cardiac troponin T levels at 96 hours reflect myocardial infarct size: A pathoanatomical study. Cardiology 2000; 93: 249-53.
55. Aartsen WM, Pelsers MM, Hermens WT, Glatz JF, Daemen MJ, Smits JF. Heart fatty acid binding protein and cardiac troponin T plasma concentrations as markers for myocardial infarction after coronary artery ligation in mice. Pflugers Archiv-Eur J Physiol 2000; 439: 416-22.
56. Johnson RN, Neutze JM, Kerr AR, Gillain B. Serum myoglobin concentration as an index of myocardial damage after cardiac surgery. Int J Cardiol 1983; 4: 33-47.
57. Vatner SF, Patrick TA, Knight DR, Manders WT, Fallon JT. Effects of calcium channel blocker on responses of blood flow, function, arrhythmias, and extent of infarction following reperfusion in conscious baboons. Circ Res 1988; 62: 105-15.
58. Rousseau-Migneron S, Tancrede G, Nadeau A. Lidocaine improves survival rate in diabetic rats submitted to acute left coronary artery ligation. Basic Res Cardiol 1990; 85: 404-10.
59. 2+signaling in inner medullary collecting duct. Hypertension 2002; 39(Suppl.): 465-69.
60. Dambisya YM, Lee TL. A thromboelastograhy study of the in vitro effects of L-arginine and L-NG-nitroarginine methyl ester on human whole blood coagulation and fibrinolysis. Blood Coagul Fibrinolysis 1996; 7: 225-61.
61. Catani MV, Bernassola F, Rossi A, Melino G. Inhibition of clotting factor XIII activity by nitric oxide. Biochem Biophys Res Comm 1998; 249: 275-8.
62. Kawabata A. Evidence that endogenous nitric oxide modulates plasma fibrinogen levels in the rat. Br J Pharmacol 1996; 117: 236-7.
63. Fleckenstein A, Kanke J, Doring HJ, Leder O. Key role of Ca in the production of noncoronarogenic myocardial necroses. Recent Adv Studies Cardiac Structure Metabolism 1975; 6: 21-32.
64. Warltier DC, Lamping KA, Pelc LR, Gross GJ. A canine model of thrombin-induced coronary artery thrombosis: Effects of intracoronary streptokinase on regional myocardial blood flow, contractile function, and infarct size. J Pharmacol Methods 1987; 18: 305-18.
65. Lippe IT, Sametz W, Sabin K, Holzer P. Inhibitory role of capsaicin-sensitive afferent neurons and nitric oxide in hemostasis. Am J Physiol 1993; 265: H1864-8.